Compare Tenet Healthcare Corporation (THC) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Vanguard International High Dividend Yield ETF — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.98B), while Vanguard International High Dividend Yield ETF trades at $100.25 (market cap $22.80B). The key difference: Tenet Healthcare Corporation and Vanguard International High Dividend Yield ETF are close in size by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Vanguard International High Dividend Yield ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Vanguard International High Dividend Yield ETF for 50 Days on average.
| THC | VYMI | |
|---|---|---|
Market Cap | $20.98B | $22.80B |
Volume | 428,008 | 748,441 |
Sector | Health | Broad Market / Factor |
52-Week High | $280.77 | $107.13 |
52-Week Low | $161.37 | $82.92 |
Typical Hold Time | 15 Days | 50 Days |
Enterprise Value | $32.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
VYMI trades at $100.23, down 1.11% today amid bearish technical signals. The ETF shows strong institutional interest with multiple firms increasing holdings recently. Recent analysis highlights VYMI's 5-year average annual return of 14.13% and 3.61% dividend yield, outperforming peers despite current technical weakness.
The outlook remains positive given VYMI's exposure to international dividend stocks benefiting from higher global rates. Key risks include currency fluctuations and concentrated financial sector exposure. Analyst sentiment leans bullish with expectations of continued international stock outperformance versus US markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
